Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs SCYNEXIS, Inc. (SCYX)

Citius Oncology, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $46.5M against $32.8M — 1.4× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (−67.2% vs −110.7%). Across the 13 metrics below, SCYNEXIS, Inc. leads on 8 and Citius Oncology, Inc. on 5.

Valuation

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 1.91 2.08
P/B 1.36 0.59 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 0.54 2.87
Earnings yield (92.16%) (62.76%) (15.94%)
Free cash flow yield (58.41%) (33.85%) 0.00%

Profitability

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.51%
Operating margin 0.00% (109.90%) 0.00%
Net margin 0.00% (49.74%) (2.45%)
Free cash flow margin 0.00% (64.67%) 0.00%
Return on equity (126.58%) (18.38%) (0.80%)
Return on assets (45.20%) (15.09%) (1.67%)
Return on invested capital (67.15%) (110.72%) 0.00%

Growth

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 682.47% 5.22%
EPS growth (last fiscal year) (9.68%) 61.36% 42.91%
Revenue growth, 5-year CAGR — 179.40% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.04
Current ratio 0.73 9.65 2.41
Net debt to EBITDA (0.40) 2.54 1.01

Dividend

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CTOR SCYX Drug Manufacturers Specialty & Generic median
Market cap 46.50m 32.84m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack